Nanobiotix S.A. (EPA:NANO)
France · Delayed Price · Currency is EUR 25.92
+1.86 (7.73%)
Oct 22, 2026, 5:35 PM CEST
Nanobiotix Market Cap
Nanobiotix has a market cap or net worth of €1.32 billion as of October 22, 2026. It is the 7,970th most valuable company in the world and the 119th biggest in France. Its market cap has increased by 34.89% in one year.
Market Cap
1.32B
Enterprise Value
1.31B
Revenue
11.51M
Global Rank
Country Rank
#119 France
PE Ratio
n/a
ChartMarket Cap Chart
Since October 29, 2012, Nanobiotix's market cap has increased from 66.13M to 1.32B, an increase of 1,891.70%. That is a compound annual growth rate of 23.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 1.32B | 39.61% |
| Dec 31, 2025 | 943.39M | 558.09% |
| Dec 31, 2024 | 143.35M | -54.17% |
| Dec 29, 2023 | 312.82M | 147.96% |
| Dec 30, 2022 | 126.16M | -50.42% |
| Dec 31, 2021 | 254.47M | -46.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ABIVAX Société Anonyme | 7.26B |
| MedinCell | 977.51M |
| Inventiva | 685.21M |
| DBV Technologies | 506.31M |
| Valneva SE | 477.15M |
| Genfit | 450.28M |
| Valerio Therapeutics Société anonyme | 205.27M |
| Transgene | 186.79M |